These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29843639)

  • 1. Lessons learned from the 2009-2010 H1N1 outbreak for the management of the 2013 silent polio outbreak.
    Sagy I; Feder-Bubis P; Novack V; Peleg-Sagy T; Greenberg D
    BMC Infect Dis; 2018 May; 18(1):241. PubMed ID: 29843639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prosocial polio vaccination in Israel.
    Wells CR; Huppert A; Fitzpatrick MC; Pandey A; Velan B; Singer BH; Bauch CT; Galvani AP
    Proc Natl Acad Sci U S A; 2020 Jun; 117(23):13138-13144. PubMed ID: 32457142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the spread of polio in an IPV-vaccinated population: lessons learned from the 2013 silent outbreak in southern Israel.
    Yaari R; Kaliner E; Grotto I; Katriel G; Moran-Gilad J; Sofer D; Mendelson E; Miller E; Huppert A; ; Anis E; Kopel E; Manor Y; Mor O; Shulman L; Singer R; Weil M
    BMC Med; 2016 Jun; 14(1):95. PubMed ID: 27334457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of EIPV in 1988 Israel polio outbreak.
    Slater PE
    Vaccine; 1993 Sep; 11(12):1269. PubMed ID: 8256508
    [No Abstract]   [Full Text] [Related]  

  • 5. A ten-year experience in control of poliomyelitis through a combination of live and killed vaccines in two developing areas.
    Tulchinsky T; Abed Y; Shaheen S; Toubassi N; Sever Y; Schoenbaum M; Handsher R
    Am J Public Health; 1989 Dec; 79(12):1648-52. PubMed ID: 2817193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stopping a polio outbreak in the post-eradication era.
    Fine PE; Sutter RW; Orenstein WA
    Dev Biol (Basel); 2001; 105():129-47; discussion 149-50. PubMed ID: 11763322
    [No Abstract]   [Full Text] [Related]  

  • 7. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass media effect on vaccines uptake during silent polio outbreak.
    Sagy I; Novack V; Gdalevich M; Greenberg D
    Vaccine; 2018 Mar; 36(12):1556-1560. PubMed ID: 29439866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing Israeli and Palestinian polio vaccination policies and the challenges of silent entry of wild poliovirus in 2013-14: a 'natural experiment'.
    Flahault A; Orenstein W; Garon J; Kew O; Bickford J; Tulchinsky T
    Int J Public Health; 2015 Nov; 60(7):765-6. PubMed ID: 26140857
    [No Abstract]   [Full Text] [Related]  

  • 10. [End phase challenges of poliomyelitis eradication programme realization].
    Jarzabek Z
    Przegl Epidemiol; 2005; 59(1):59-68. PubMed ID: 16013411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pandemic influenza preparedness in the WHO African region: are we ready yet?
    Sambala EZ; Kanyenda T; Iwu CJ; Iwu CD; Jaca A; Wiysonge CS
    BMC Infect Dis; 2018 Nov; 18(1):567. PubMed ID: 30428846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine coverage and determinants of incomplete vaccination in children aged 12-23 months in Dschang, West Region, Cameroon: a cross-sectional survey during a polio outbreak.
    Russo G; Miglietta A; Pezzotti P; Biguioh RM; Bouting Mayaka G; Sobze MS; Stefanelli P; Vullo V; Rezza G
    BMC Public Health; 2015 Jul; 15():630. PubMed ID: 26156158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and introduction of inactivated poliovirus vaccines derived from Sabin strains in Japan.
    Shimizu H
    Vaccine; 2016 Apr; 34(16):1975-85. PubMed ID: 25448090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strengthening acute flaccid paralysis surveillance post Ebola virus disease outbreak 2015 - 2017: the Liberia experience.
    Clarke A; Blidi N; Dahn B; Agbo C; Tuopileyi R; Rude MJ; Williams GS; Seid M; Gasasira A; Wambai Z; Skrip L; Nagbe T; Nyenswah T; Chukwudi JO; Johnson T; Talisuna A; Yahaya AA; Rajatonirina S; Fall IS
    Pan Afr Med J; 2019; 33(Suppl 2):2. PubMed ID: 31402963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk management in a polio-free world.
    Bruce Aylward R; Sutter RW; Cochi SL; Thompson KM; Jafari H; Heymann D
    Risk Anal; 2006 Dec; 26(6):1441-8. PubMed ID: 17184391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demand-side determinants of timely vaccination of oral polio vaccine in social mobilization network areas of CORE Group polio project in Uttar Pradesh, India.
    Choudhary M; Solomon R; Awale J; Dey R
    BMC Infect Dis; 2018 May; 18(1):222. PubMed ID: 29769034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silent reintroduction of wild-type poliovirus to Israel, 2013 - risk communication challenges in an argumentative atmosphere.
    Kaliner E; Moran-Gilad J; Grotto I; Somekh E; Kopel E; Gdalevich M; Shimron E; Amikam Y; Leventhal A; Lev B; Gamzu R
    Euro Surveill; 2014 Feb; 19(7):20703. PubMed ID: 24576475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pakistan's expanded programme on immunization: an overview in the context of polio eradication and strategies for improving coverage.
    Owais A; Khowaja AR; Ali SA; Zaidi AK
    Vaccine; 2013 Jul; 31(33):3313-9. PubMed ID: 23707167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to an intercalated enhanced inactivated polio vaccine/oral polio vaccine programme in Israel: impact on the control of poliomyelitis.
    Swartz TA; Handsher R; Manor Y; Stoeckel P; Barkay A; Mendelson E; Leventhal A
    Vaccine; 1998 Dec; 16(20):2090-5. PubMed ID: 9796069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivated poliovirus vaccine following oral poliovirus vaccine cessation.
    Wkly Epidemiol Rec; 2006 Apr; 81(15):137-44. PubMed ID: 16673508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.